Formation and distribution of ZnO nanoparticles and its effect on E. coli in the presence of sepiolite and silica within the chitosan matrix via sonochemistry

Effective drug combinations of betulinic acid and ceranib-2 loaded Zn:MnO2 doped-polymeric nanocarriers against PC-3 prostate cancer cells

The development of theranostic nanocarriers with synergistic drug combinations has received considerable attention due to their improved pharmaceutical activity. Herein, we reported an investigation about the in-vitro anticancer activity of ceranib-2 (Cer), betulinic acid (BA), and the combination of betulinic acid and ceranib-2 (BA-Cer) against PC-3 prostate cancer cells. For this purpose, first we designed a suitable nanocarrier using a novel Zn:MnO₂ nanocomposite (NCs) and gallic acid (GA)-polylactic acid (PLA)-Alginate polymeric shell with nanoscale particle size and good stability. Chemical statements, morphology, and physicochemical properties of the nanocarrier have been illuminated with advanced characterization techniques. According to the transmission electron microscopy (TEM) results, Zn:MnO₂ NCs had a spherical and monodispersed morphology with a 2.03 ± 0.67 nm diameter. Moreover, vibrating-sample magnetometer (VSM) results showed that Zn:MnO₂ had paramagnetic properties with a saturation magnetization (Ms) value of 1.136 emu/g. Additionally, the in-vitro cytotoxic effects of the single and binary drugs loaded Zn:MnO₂-doped polymeric nanocarriers against PC-3 prostate cancer cells were investigated. According to the results, there was no significant cytotoxic effect of free BA and Cer against PC-3 prostate cancer cells. However, BA/Zn:MnO₂@GA-PLA-Alginate NCs, BA-Cer/Zn:MnO₂ @GA-PLA-Alginate NCs and free BA-Cer had IC₅₀ values of 6.498, 7.351, and 18.571 μg/mL, respectively. Consequently, BA-Cer/Zn:MnO₂@GA-PLA-Alginate is a nanocarrier with good stability, enhanced drug loading and release capacity for hydrophobic drugs, as well as being used as both imaging and treatment agent due to its magnetic properties. Furthermore, BA and Cer drug combination showed great promise in prostate cancer therapy which is known to be resulted high drug resistance. We strongly believed that this work could lead to an investigation of the molecular mechanisms of BA-mediated cancer theapy.

Synthesis of (ZrO2-Al2O3)/GO nanocomposite by sonochemical method and the mechanism analysis of its high defluoridation

A nanocomposite of (ZrO₂-Al₂O₃)/GO was successfully synthesized by a simple sonochemical method in this study. A special 3D network was formed in (ZrO₂-Al₂O₃)/GO, which produced a large surface area and good distribution of metal oxide nanoparticles. The as-synthesized (ZrO₂-Al₂O₃)/GO exhibits a maximum fluoride adsorption capacity of 62.2 mg/g, and an adsorption ability of 13.80 mg/g when the F^- equilibrium concentration is 1 mg/L, both of which are higher than most previously reported defluoridation adsorbents, indicating that it is among the top adsorbents. Large amounts of drinking water contaminated by F^- can be treated by (ZrO₂-Al₂O₃)/GO to meet the WHO limit, indicating the high potential for practical application of the adsorbent. Based on the experimental analysis, the origin of the high defluoridation performance and the adsorption mechanism were discussed in detail. Due to the simple preparation, easy operation and high performance, the adsorbent and the related sonochemical method are considered to be significant for developing highly effective adsorbents.